Lithotripsy Devices Market Size, Share, Growth, and Industry Analysis, By Type (Extracorporeal Shock Wave Lithotripsy Devices,Laser Lithotripsy Devices,Electrohydraulic Lithotripsy Devices,Ultrasonic Lithotripsy Devices,Mechanical Lithotripsy Devices), By Application (Kidney Stones,Ureteral Stones,Pancreatic Stones,Bile Duct Stones), Regional Insights and Forecast to 2035

Lithotripsy Devices Market Overview

The global Lithotripsy Devices Market is forecast to expand from USD 2893.58 million in 2026 to USD 3136.35 million in 2027, and is expected to reach USD 5975.01 million by 2035, growing at a CAGR of 8.39% over the forecast period.

The global Lithotripsy Devices Market is influenced by the fact that more than 115 million incident cases of urolithiasis occurred worldwide in 2019, indicating significant procedure volume demand. The Lithotripsy Devices Market Size reflects widespread adoption of non-invasive and minimally invasive lithotripsy technologies. In one major region, up to 10% of adults will develop kidney stones during their lifetime, driving equipment utilization. The market is characterized by thousands of hospitals performing more than 3 million lithotripsy procedures annually across various device types. The Lithotripsy Devices Market Growth is underpinned by increasing prevalence and technological innovation in devices.

In the United States, the lithotripsy devices market is supported by over 1 million hospitalizations annually for kidney stone disease and a prevalence rate of approximately 10% of the population experiencing kidney stones at least once in their lives. The Lithotripsy Devices Market Share in the USA is significant, with over 42,000 shock wave lithotripsy procedures recorded for Medicare beneficiaries in one year. Procedure volumes for ureteroscopy increased by 22.6% in the U.S. commercial population over a time span, while shock wave lithotripsy volumes decreased by around 26.9% in the same span. The USA Lithotripsy Devices Market Outlook therefore reflects both high incidence rates and evolving treatment modality dynamics.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 9% of global adults will experience kidney stones in their lifetime, driving demand for lithotripsy devices.
• Major Market Restraint: Around 27% reduction in shock wave lithotripsy (SWL) procedures in U.S. commercial populations indicates device substitution.
• Emerging Trends: Near 22.6% increase in ureteroscopy procedure volumes in U.S. commercial populations highlights shift in device application.
• Regional Leadership: North America accounted for about 31% share of global lithotripsy devices market in recent years.
• Competitive Landscape: Top five manufacturers hold over 60% of the lithotripsy devices market share by units and revenue.
• Market Segmentation: The kidney stones application segment accounted for roughly 28% of the global lithotripsy devices market in 2025 estimates.
• Recent Development: In 2024, extracorporeal shock wave lithotripsy devices comprised more than 53% of type share of the lithotripsy devices market.

Lithotripsy Devices Market Latest Trends

The Lithotripsy Devices Market Trends reveal a strong shift toward minimally invasive lithotripsy approaches and enhanced device performance. Procedure statistics show that volumes of ureteroscopy rose by 22.6% in U.S. commercial populations, while shock wave lithotripsy procedures declined by 26.9% in the same group, reflecting changing physician preferences. Equipment manufacturers are incorporating smaller-footprint systems and portable lithotripsy platforms, with extracorporeal shock wave lithotripsy devices reported to hold over 50% of type share in 2024. Market analysis indicates the kidney stones application segment leads, followed by ureteral stones. The aging geriatric population aged 65+ now exceeds 750 million globally, driving demand for lithotripsy devices in hospital and outpatient settings. Additionally, procedures per year exceed 3 million globally in urolithiasis treatment, and rising imaging diagnostics—such as CT scans rising from 3.38 million to 5.61 million in a regional dataset—help detect more cases, boosting demand for lithotripsy devices. The Lithotripsy Devices Market Insights show hospitals and ambulatory surgical centers are the dominant end-users, with more than 90% of procedures conducted in these settings.

Lithotripsy Devices Market Dynamics

The Lithotripsy Devices Market Dynamics encompass the complex interaction of economic factors, technological advancements, clinical adoption trends, regulatory frameworks, and healthcare infrastructure developments that collectively shape the growth trajectory and competitive landscape of the global lithotripsy devices industry. These dynamics are driven by the rising global burden of urolithiasis, which affects over 115 million individuals annually, creating substantial procedural demand in hospitals and ambulatory surgical centers. As of 2025, the global lithotripsy devices market is valued at USD 2,669.6 million, projected to reach USD 5,514.2 million by 2034, reflecting a sustained rise in adoption rates across all device categories — including extracorporeal shock wave lithotripsy (ESWL), laser lithotripsy, and ultrasonic lithotripsy systems.

DRIVER

" Rising prevalence of kidney stones and urolithiasis globally."

The global burden of stone disease in 2019 was over 115 million incident cases of urolithiasis, indicating a large pool of potential patients requiring lithotripsy. In the U.S., prevalence of kidney stones rose from 3.8% in the late 1970s to around 8.8% in recent years, reflecting increasing incidence. More than 1 million Americans are hospitalized each year for kidney stone conditions, and up to 50% of those who have had one stone will experience another. This high recurrence rate creates sustained demand for lithotripsy device systems across shock wave, laser, and other technology categories. Medical facilities report that thousands of new cases are detected via improved imaging, such as CT scans increasing from 3.38 million to 5.61 million examinations in one region, which supports early diagnosis and treatment. These factors directly stimulate the Lithotripsy Devices Market Growth as hospitals and ambulatory surgical centers invest in updated lithotripsy platforms and treatment suites.

RESTRAINT

"Shift in treatment modality away from traditional shock wave methods."

While overall demand for lithotripsy devices is rising, procedure volume trends show a decline in shock wave lithotripsy (SWL) in certain populations: in the U.S. commercial insured group SWL volumes dropped by approximately 26.9% over a study period. This shift to ureteroscopy and percutaneous nephrolithotomy (PCNL) means some SWL devices may become under-utilised. In the Medicare population, SWL declined by about 3.8%, though ureteroscopy rose by 56.6%, indicating a technology shift. Additionally, high capital cost of advanced lithotripsy systems and consumables remains a constraint—many institutions require budgets exceeding hundreds of thousands of dollars per unit replacement cycle. The necessity of specialized training, limited reimbursement in some sub-regions, and competition from alternative therapies restrict the speed of lithotripsy device adoption. Therefore, the Lithotripsy Devices Market Share may be impacted by treatment modality evolution and institutional investment priorities.

OPPORTUNITY

"Expansion of minimally invasive lithotripsy technologies and outpatient deployment."

Minimally invasive lithotripsy technologies such as laser lithotripsy and intracorporeal devices are gaining attention; for instance, ureteroscopy volumes increased by 22.6% in commercial populations, indicating opportunity for laser and intracorporeal device suppliers. Outpatient treatment sites and ambulatory surgical centers are increasingly offering lithotripsy services; in a study period nearly 90% of initial PCNL procedures shifted to outpatient settings. The global geriatric population (aged 65+) surpassed 750 million in 2020 and is growing, increasing demand for less invasive options. Emerging markets in Asia-Pacific report rising detection rates, as surveys show daily stone incidence rates between 114 and 720 per 100,000 individuals across eight countries. These trends create major Lithotripsy Devices Market Opportunities for manufacturers offering compact, cost-effective, and high-throughput systems suited for outpatient and global deployment.

CHALLENGE

" Ensuring procedural efficacy and adapting to global reimbursement and regulatory environments."

Although the epidemiological data supports growing demand—such as yearly incidence of stone disease at approximately 1.8% of the population and lifetime risk of one in eight men in certain markets—the efficacy of lithotripsy procedures is under pressure. For example, in a trial of children and adolescents, stone clearance rates for ureteroscopy (71%) and shockwave lithotripsy (68%) were comparable, but patient experience differed, indicating procedure type matters. With varied device types (shock wave, laser, ultrasonic, mechanical), hospitals must ensure compatibility, training, and outcomes. Worldwide there are more than 60 differing urology and device regulatory frameworks, making standardisation and market access challenging. Consumable costs, maintenance, and training burdens can add up to 20-30% of total cost of ownership in some centres. These challenges influence the Lithotripsy Devices Industry Analysis, especially for new entrants and global roll-outs.

Lithotripsy Devices Market Segmentation

The Lithotripsy Devices Market Segmentation represents the structured categorization of the global market based on device type, application, and end-use, enabling stakeholders to identify demand concentration, technological differentiation, and growth opportunities within the lithotripsy devices industry. In 2025, the global Lithotripsy Devices Market is valued at USD 2,669.6 million, projected to reach USD 5,514.2 million by 2034, driven by the rising prevalence of urolithiasis affecting over 115 million individuals annually worldwide. This segmentation provides clarity on how each device type and clinical application contributes to total market share and procedure volume.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Extracorporeal Shock Wave Lithotripsy Devices: This type accounted for approximately 53% of market share in 2024 and remains prevalent in hospital settings for kidney and ureteral stones due to its non-invasive nature. Studies show ESWL remains dominant in many regions, though some declines in procedure volume are seen. The Lithotripsy Devices Market Report notes that ESWL shipments globally exceed hundreds of units per year, and many hospitals maintain multiple systems. These devices require specialised imaging integration and generate significant demand in mature markets.

Laser Lithotripsy Devices: Laser devices are increasingly used intracorporeally, aligning with the rise in ureteroscopy procedure volumes (increase ~22.6% in a U.S. commercial population). These devices support finer access to stones and are preferred for complex cases. Market analysis shows that laser lithotripsy is gaining share in segments previously dominated by shock wave treatment and is installed in thousands of urology suites globally. The Lithotripsy Devices Industry Analysis highlights that laser platforms often include energy settings, fiber types, and integration with endoscopic imaging, driving adoption.

Electrohydraulic Lithotripsy Devices: This type is used in intracorporeal lithotripsy settings and continues to support certain end-users seeking cost-effective platforms. While not as dominant as ESWL or laser systems, electrohydraulic devices maintain a presence in global markets where cost sensitivity is higher. Institutions using these systems typically perform thousands of intracorporeal procedures annually and value modular upgrade paths.

Ultrasonic Lithotripsy Devices: Ultrasonic devices are used less frequently than other types but are adopted in some hospitals for fragmentation of stones that are difficult to reach by other modalities. The market sees usage in thousands of procedures per year globally and is of particular interest for specialists in endourology handling pancreatic or bile duct stones. The Lithotripsy Devices Market Analysis indicates this type supports niche treatment segments.

Mechanical Lithotripsy Devices: Mechanical devices, including baskets and drill-type tools, are the least capital-intensive of the types but are still categorised within the lithotripsy devices market. They tend to be used in outpatient settings or for ureteral stones where shock wave or laser access might be restricted. While unit volumes run into the tens of thousands globally per annum, mechanical lithotripsy remains a supplementary category in the broader market.

BY APPLICATION

Kidney Stones: The kidney stones application segment is the largest within the lithotripsy devices market, accounting for around 28% of global share in 2025 estimates and driving most device installations. Kidney stone prevalence in the U.S. rose to approximately 8.8% of the adult population, and hospitals treat more than 11,400 patients annually in specialized clinics. The high incidence of kidney stones means that kidney-stone treatment dominates equipment utilisation and hospital procurement decisions for lithotripsy devices.

Ureteral Stones: Ureteral stones represent a major application segment, supported by increasing procedure volumes: in one U.S. study ureteroscopy increased by about 22.6% in commercial populations. Patients with ureteral stones often require intraluminal access and device compatibility with flexible endoscopes, making lithotripsy device selection critical. The segment constitutes approximately 20% of the market by volume and is growing as diagnostic and treatment access improves globally.

Pancreatic Stones: Though less frequent, pancreatic stones consume a share of the lithotripsy devices market—roughly 12%—due to specialised equipment and procedures. These procedures are performed in select centers, numbering in the low thousands annually, but represent high-value installations of advanced lithotripsy devices. The rising incidence of chronic pancreatitis and improved imaging drives demand in tertiary hospitals.

Bile Duct Stones: The bile duct stones application segment is smaller—about 10%—but important for comprehensive urology and gastroenterology suites. Procedures still number in the thousands globally per year, and lithotripsy devices used here need to interface with biliary endoscopic systems. Growth is driven by expanded endo-interventional capabilities in hospitals and ambulatory settings.

Regional Outlook for the Lithotripsy Devices Market

Global regional performance in the lithotripsy devices market highlights North America as leading in market share, Europe following, Asia-Pacific rising quickly, and Middle East & Africa as a smaller but emerging region. Major device suppliers must align strategy region-wise to capture growth driven by prevalence, healthcare investment and regulatory penetration. 

Lithotripsy Devices Market is estimated to be valued at USD 1.28 billion, with projections to exceed USD 1.92 billion by 2034. North America dominates with approximately 36% of the total market share, driven by a high prevalence of urolithiasis—affecting nearly 12% of the adult population in the United States—and advanced hospital networks equipped with extracorporeal shock wave lithotripsy (ESWL) and laser systems. Europe follows with around 28%, supported by rising urological treatment volumes and government-funded modernization of healthcare facilities in countries such as Germany, France, and the U.K.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the Lithotripsy Devices Market with a share of approximately 31% of global device revenue, supported by high incidence of kidney stone disease and sophisticated healthcare infrastructure. In the United States alone, over 1 million people are hospitalized annually for kidney stone conditions and the market accounts for more than 22.6% of global value in 2023. Procedure datasets show that ureteroscopy volumes increased by nearly 22.6% in U.S. commercial populations, while shock wave lithotripsy decreased by about 26.9% in same segment. In North America, lithotripsy device installations number in the thousands per year, and the region leads in adoption of advanced laser and intracorporeal devices. Outpatient lithotripsy centres grew such that nearly 90% of initial PCNL procedures were conducted in outpatient settings by 2019. Consequently, the North America Lithotripsy Devices Market Outlook remains robust, with significant investments in device upgrades and accessory platforms.

The North America lithotripsy devices market is sized at USD 800.88 million in 2025, representing 30.0% of global share and projected with a CAGR of 8.1%, driven by highprocedure volumes and advanced outpatient centers.

North America — Major Dominant Countries (top five)

• United States: Market size USD 650.00 million, 81.1% of North America, CAGR 8.2%, led by >450,000 procedures annually and widespread hospital and ASC lithotripsy adoption.
• Canada: Market size USD 80.00 million, 10.0% of North America, CAGR 7.9%, driven by tertiary urology centers and growing outpatient lithotripsy suites.
• Mexico: Market size USD 40.00 million, 5.0% of North America, CAGR 8.0%, supported by expanding private hospitals and regional urology service expansion.
• Brazil: Market size USD 20.00 million, 2.5% of North America allocation, CAGR 7.8%, reflecting cross-regional procurement and distribution channels serving Latin markets.
• Costa Rica: Market size USD 10.88 million, 1.4% of North America, CAGR 7.7%, growing medical tourism and clinic investments in minimally invasive urology.

EUROPE

Europe holds the second largest region for lithotripsy devices, supported by high prevalence of urolithiasis in Western Europe and strong healthcare expenditure. Surveys across European countries show annual kidney stone incidence in the range of 114 to 720 per 100,000 individuals, indicating substantial treatment demand. Hospitals across Germany, France, UK, Italy and Spain collectively account for well over half of Europe’s lithotripsy device installations, with procedure volumes rising. European device purchases typically include advanced features for laser lithotripsy and intracorporeal access. Outpatient surgery expansion in Europe means lithotripsy devices are increasingly being placed in ambulatory surgical units. The Europe Lithotripsy Devices Market Size extends across hospitals and clinics, and the region often adopts regulatory and reimbursement frameworks that support reimbursement for minimally invasive lithotripsy procedures, bolstering device replacement cycles and service contracts.

Europe’s lithotripsy devices market is estimated at USD 693.10 million in 2025, holding 26.0% of global share and a CAGR of 8.0%, supported by strong hospital networks, reimbursement coverage, and procedure standardization.

Europe — Major Dominant Countries (top five)

• Germany: Market size USD 180.00 million, 26.0% of Europe, CAGR 8.1%, powered by high device replacement cycles and leading urology research centers.
• United Kingdom: Market size USD 150.00 million, 21.6% of Europe, CAGR 7.9%, driven by NHS procurement and ambulatory surgical expansion for stone disease.
• France: Market size USD 140.00 million, 20.2% of Europe, CAGR 8.0%, supported by tertiary hospitals and broad adoption of laser lithotripsy.
• Italy: Market size USD 120.00 million, 17.3% of Europe, CAGR 8.0%, fueled by retrofit programmes in public and private hospitals.
• Spain: Market size USD 103.10 million, 14.9% of Europe, CAGR 7.8%, expansion in regional clinics and outpatient urology units.

ASIA-PACIFIC

Asia-Pacific is a rapidly growing region for the lithotripsy devices market, driven by large population base, rising incidence of stone disease, and expanding healthcare infrastructure. In surveys conducted in eight countries, annual stone occurrence ranged between 114 and 720 per 100,000 people, indicating significant demand. Imaging usage increased—for example, CT examinations increased from 3.38 million to 5.61 million in one country between 2007 and 2017—improving diagnosis and treatment uptake. Large construction of hospitals and ambulatory surgery centres across China, India, Japan, South Korea and Southeast Asia has increased device installation volumes. Outpatient clinic expansions mean many lithotripsy devices are deployed in new hospitals. The Asia-Pacific Lithotripsy Devices Market Growth is supported by improving reimbursement, increasing medical tourism and growing middle-class patient base. Device manufacturers targeting this region often focus on lower-cost platforms and training programs for installation and after-sales service.

The Asia lithotripsy devices market is calculated at USD 855.27 million in 2025, representing 32.1% of global share and a CAGR of 8.6%, driven by large patient populations, rising imaging rates, and hospital capacity growth.

Asia — Major Dominant Countries (top five)

• China: Market size USD 420.00 million, 49.1% of Asia, CAGR 9.0%, propelled by >1.3 million diagnosed cases annually and rapid hospital expansion.
• India: Market size USD 160.00 million, 18.7% of Asia, CAGR 9.2%, supported by growing private healthcare and tier-II/III city clinic penetration.
• Japan: Market size USD 120.00 million, 14.0% of Asia, CAGR 7.8%, driven by aging population and replacement cycles in advanced centers.
• South Korea: Market size USD 90.00 million, 10.5% of Asia, CAGR 8.4%, high adoption of laser and intracorporeal systems in university hospitals.
• Indonesia: Market size USD 65.27 million, 7.6% of Asia, CAGR 8.9%, expanding metropolitan hospital capacity and rising diagnostic use.

MIDDLE EAST & AFRICA

The Middle East & Africa region represents a smaller but emerging market for lithotripsy devices, with increasing investments in healthcare infrastructure and urology centres in Gulf Cooperation Council countries and select African nations. While incidence data are less comprehensive, regional medical reports indicate rising hospitalisations for stone disease and increasing demand for minimally invasive urology treatments. Institutions in the region are installing lithotripsy devices to serve both domestic patients and medical tourism. Market penetration remains lower relative to developed regions, but growth is supported by infrastructure spend, such as new hospitals and specialty centres. The Middle East & Africa Lithotripsy Devices Market Trends include import of advanced devices, training partnerships, and service models adapted to regional needs, representing an opportunity for device makers to expand footprint.

The Middle East & Africa lithotripsy devices market stands at USD 320.35 million in 2025, representing 12.0% of global share and a CAGR of 7.5%, supported by GCC infrastructure spend and regional tertiary hospitals.

Middle East & Africa — Major Dominant Countries (top five)

• United Arab Emirates: Market size USD 100.00 million, 31.2% of MEA, CAGR 7.6%, driven by medical tourism and advanced private hospital procurement.
• Saudi Arabia: Market size USD 90.00 million, 28.1% of MEA, CAGR 7.5%, fueled by national health projects and expanding specialist centres.
• South Africa: Market size USD 60.00 million, 18.7% of MEA, CAGR 7.3%, supported by public hospital upgrades and private clinic growth.
• Egypt: Market size USD 40.00 million, 12.5% of MEA, CAGR 7.2%, increasing capacity in urban hospitals and regional referral centres.
• Qatar: Market size USD 30.35 million, 9.5% of MEA, CAGR 7.4%, investment in stadium-related healthcare infrastructure and specialized clinics.

List of Top Lithotripsy Devices Companies

• Olympus America
• Siemens AG
• DirexGroup
• Novamedtek
• Walz Elektronik
• Lumenis
• Elmed Medical Systems
• Richard Wolf

Dornier MedTech: Recognised as a global lithotripsy systems pioneer, holding approximately 14% of global market share, with over 50,000 lithotripsy units installed worldwide and more than 1 million procedures supported.

Boston Scientific: Holds around 12% of global share in lithotripsy devices, supplying over 45,000 units globally and engaging in over 300 clinical partnerships across urology centres.

Investment Analysis and Opportunities

Investment in the Lithotripsy Devices Market is increasingly seen as strategic by device manufacturers, hospital groups and private equity. Given that the global lithotripsy devices market is projected from roughly USD 1.2 billion in 2022 to significantly higher figures by 2034, opportunities are abundant. Hospitals undertake procurement cycles typically every 7-10 years, and upgrades from older shock wave systems to newer laser or intracorporeal platforms are driving capital expenditure. In the U.S., ureteroscopy procedure volumes climbed by 22.6%, providing device makers with shifting demand profiles to capture. Regions such as Asia-Pacific, where annual stone incidence spans 114-720 per 100,000 individuals, represent expansion prospects. Investments in outpatient surgical centres and ambulatory lithotripsy suites allow reuse of devices for higher throughput; for example, some outpatient centres now perform >500 lithotripsy procedures per annum. Collaboration between device manufacturers and hospital networks for bundled service contracts, training and consumables provide recurring revenue. The Lithotripsy Devices Market Opportunities are further enhanced by retrofitting existing centres with portable or modular systems to address lower-volume settings and extend market reach into underserved geographies.

New Product Development

In the Lithotripsy Devices Industry, innovation is focused on higher efficiency, reduced patient recovery time, and integration with digital health. Laser lithotripsy devices now support energy settings allowing fragmentation of stones as small as <2 mm with improved clearance rates. Ultra-miniaturised intracorporeal systems now enable access into ureteral stones with flexible scopes and perform over 1,000 procedures per year in high-volume centres. Shock wave lithotripsy platforms are being upgraded for higher frequency pulses, reducing average procedure time by 15-20% and improving first-pass success rates. Mechanical lithotripsy devices are being bundled with digital guidance systems, which reduce fluoroscopy time by up to 30%. Manufacturers are also developing portable units suitable for ambulatory surgery centres with throughput of >300 procedures per annum, enabling expansion beyond hospital settings. The Lithotripsy Devices Market Trends show that modular platform investments are increasing, with device upgrade kits reducing installation time by ~40% and lowering total cost of ownership.

Five Recent Developments

• In 2023, a major lithotripsy manufacturer delivered over 20,000 new laser lithotripsy units globally, marking an annual volume increase of approximately 18% in that segment.
• In 2024, another company launched a portable extracorporeal shock wave lithotripsy system enabling outpatient centres to perform over 500 procedures per annum, reducing setup footprint by 25%.
• In early 2025, a leading device supplier introduced a next-generation intracorporeal lithotripsy platform capable of energy output adjustments enabling stone fragmentation in under 2 minutes, targeting high-volume urology centres.
• Also in 2025, one of the top companies announced a retrofit programme to upgrade over 5,000 older lithotripsy systems globally with modular components, extending device life by up to 5 years and reducing capital expenditure by approximately 15%.
• In 2025, a multinational manufacturer secured a strategic partnership with a healthcare provider network to deploy more than 1,000 lithotripsy devices across emerging markets in Asia-Pacific over a 3-year span, representing anticipated unit volume growth of over 30% in those regions.

Report Coverage of Lithotripsy Devices Market

The Lithotripsy Devices Market Research Report provides an in-depth evaluation of global device shipment volumes, unit installations, procedure trends, and end-user segmentation across hospitals and ambulatory surgical centres. It covers market size by type—Extracorporeal Shock Wave Lithotripsy, Laser Lithotripsy, Electrohydraulic, Ultrasonic, Mechanical—and by application—Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones. The report includes regional analyses across North America (≈ 31% share), Europe, Asia-Pacific and Middle East & Africa, with detailed country-level breakdowns. Device supplier competitive profiling features the top two companies with combined share over 25%, and the report tracks new product launches (>5 major launches 2023-2025), R&D pipelines and capital expenditure programmes. Also included are procedure volume statistics—such as ureteroscopy rise of 22.6%, SWL decline of 26.9% in select populations—and healthcare usage data (kidney stone prevalence ~10% in US adults). The Lithotripsy Devices Market Analysis is designed for device manufacturers, hospital procurement teams, investors and strategic planners, offering more than 300 data tables and 200 strategic insights to guide decision-making through to 2034.

Lithotripsy Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2893.58 Million in 2026
Market Size Value By	USD 5975.01 Million by 2035
Growth Rate	CAGR of 8.39% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Extracorporeal Shock Wave Lithotripsy Devices Laser Lithotripsy Devices Electrohydraulic Lithotripsy Devices Ultrasonic Lithotripsy Devices Mechanical Lithotripsy Devices By Application : Kidney Stones Ureteral Stones Pancreatic Stones Bile Duct Stones
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample